Position in NVS
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$242,602
+$13,783 QoQ
Shares Held
1,548
+3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,229
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Westmount Partners, LLC holds $10,104,775 across 9 Drug Manufacturers - General names. NVS ranks #9 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,289 | $2,745,495 | |
| 2 | JNJ |
Johnson & Johnson
|
9,734 | $2,472,143 | |
| 3 | ABBV |
AbbVie Inc.
|
5,727 | $1,441,142 | |
| 4 | AMGN |
Amgen Inc
|
3,735 | $1,352,518 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,013 | $644,170 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
10,185 | $586,859 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,887 | $364,743 | |
| 8 | PFE |
Pfizer Inc
|
10,594 | $255,103 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,602 | 1,548 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $228,819 | 1,498 | Shares | Sole | 2026-04-16 | |
| No filing history on record for this holder in this stock. | ||||||